SE421615B - Sett att framstella nya tiazolderivat - Google Patents
Sett att framstella nya tiazolderivatInfo
- Publication number
- SE421615B SE421615B SE7311181A SE7311181A SE421615B SE 421615 B SE421615 B SE 421615B SE 7311181 A SE7311181 A SE 7311181A SE 7311181 A SE7311181 A SE 7311181A SE 421615 B SE421615 B SE 421615B
- Authority
- SE
- Sweden
- Prior art keywords
- tiazle
- want
- derivatives
- make new
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
- C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
- C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D277/36—Sulfur atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Thiazole And Isothizaole Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP47082574A JPS5238559B2 (xx) | 1972-08-17 | 1972-08-17 | |
JP48039354A JPS49125359A (xx) | 1973-04-05 | 1973-04-05 | |
ZA00741280A ZA741280B (en) | 1972-08-17 | 1974-02-26 | Thiazole derivatives |
Publications (1)
Publication Number | Publication Date |
---|---|
SE421615B true SE421615B (sv) | 1982-01-18 |
Family
ID=27290112
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE7311181A SE421615B (sv) | 1972-08-17 | 1973-08-16 | Sett att framstella nya tiazolderivat |
Country Status (10)
Country | Link |
---|---|
US (1) | US3932400A (xx) |
CA (1) | CA991640A (xx) |
CH (1) | CH581640A5 (xx) |
DE (1) | DE2341753C2 (xx) |
DK (1) | DK149893C (xx) |
FR (1) | FR2196162B1 (xx) |
GB (1) | GB1435139A (xx) |
NL (1) | NL179733C (xx) |
SE (1) | SE421615B (xx) |
ZA (1) | ZA741280B (xx) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4001421A (en) * | 1971-10-27 | 1977-01-04 | Syntex (U.S.A.) Inc. | Thiazole cardiovascular agents |
US4119718A (en) * | 1977-05-02 | 1978-10-10 | Merck & Co., Inc. | 3-Amino-2-oxy-propoxy-substituted isothiazoles |
US4259341A (en) * | 1977-06-01 | 1981-03-31 | Merck & Co., Inc. | Di- and tri-substituted thiazoles |
US4260609A (en) * | 1977-06-01 | 1981-04-07 | Merck & Co., Inc. | Di- and tri- substituted thiazoles |
US4396625A (en) * | 1980-05-13 | 1983-08-02 | Sumitomo Chemical Company, Limited | Treatment of glaucoma or ocular hypertension and ophthalmic composition |
US4670450A (en) * | 1985-11-13 | 1987-06-02 | Merrell Dow Pharmaceuticals Inc. | Cardiotonic thiazolones |
MXPA05001958A (es) | 2002-08-19 | 2005-04-28 | Pfizer Prod Inc | Terapia de combinacion para enfermedades hiperproliferativas. |
EA009646B1 (ru) * | 2003-05-30 | 2008-02-28 | Рэнбакси Лабораториз Лтд. | Замещённые производные пиррола и их применение в качестве ингибиторов hmg-coa |
US20050037063A1 (en) * | 2003-07-21 | 2005-02-17 | Bolton Anthony E. | Combined therapies |
US20060063803A1 (en) * | 2004-09-23 | 2006-03-23 | Pfizer Inc | 4-Amino substituted-2-substituted-1,2,3,4-tetrahydroquinoline compounds |
MX2007005137A (es) * | 2004-11-23 | 2007-06-22 | Warner Lambert Co | Derivados del acido 7-(2h-pyrazol-3-il)-3, 5-dihidroxi-heptanoico como inhibidores de hmg co-a reductasa para el tratamiento de lipidemia. |
GT200600381A (es) | 2005-08-25 | 2007-03-28 | Compuestos organicos | |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
AU2006313430B2 (en) * | 2005-11-08 | 2012-09-06 | Ranbaxy Laboratories Limited | Process for (3R,5R)-7-[2-(4-fluorophenyl)-5-isopropyl-3-phenyl-4- [(4-hydroxy methyl phenyl amino) carbonyl]-pyrrol-1-yl]-3, 5-dihydroxy-heptanoic acid hemi calcium salt |
US20090226420A1 (en) * | 2005-11-10 | 2009-09-10 | Elizabeth Hauser | Methods of Determining the Risk of Developing Coronary Artery Disease |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
US7514566B2 (en) * | 2006-01-18 | 2009-04-07 | Amgen, Inc. | Thiazole compounds and methods of use |
US8383660B2 (en) | 2006-03-10 | 2013-02-26 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
US7919506B2 (en) | 2006-03-10 | 2011-04-05 | Pfizer Inc. | Dibenzyl amine compounds and derivatives |
TW200744583A (en) * | 2006-03-14 | 2007-12-16 | Ranbaxy Lab Ltd | Statin stabilizing dosage formulations |
MX2009000439A (es) * | 2006-07-14 | 2009-02-04 | Ranbaxy Lab Ltd | Formas polimorficas de un inhibidor de hmg-coa reductasa y usos de las mismas. |
CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
CA2693473A1 (en) * | 2007-07-17 | 2009-01-22 | Amgen Inc. | Thiadiazole modulators of pkb |
CN105143203A (zh) | 2013-04-17 | 2015-12-09 | 辉瑞大药厂 | 用于治疗心血管疾病的n-哌啶-3-基苯甲酰胺衍生物 |
WO2016055901A1 (en) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Substituted amide compounds |
CN104530033B (zh) * | 2014-12-26 | 2017-07-07 | 江西百神药业股份有限公司 | 一种盐酸阿罗洛尔的制备工艺新方法 |
CN105646472A (zh) * | 2016-02-29 | 2016-06-08 | 山东齐都药业有限公司 | 一种盐酸阿罗洛尔的制备方法 |
CN113574055B (zh) | 2019-01-18 | 2024-07-23 | 阿斯利康(瑞典)有限公司 | Pcsk9抑制剂及其使用方法 |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA599475A (en) * | 1960-06-07 | W. Harman Marion | Aminoethylthiazoles | |
US2221147A (en) * | 1938-11-18 | 1940-11-12 | Goodrich Co B F | Preparation of aminated esters of sulphydryl compounds |
US3228952A (en) * | 1962-06-27 | 1966-01-11 | Dow Chemical Co | Thiazole thioethers |
US3158623A (en) * | 1963-03-01 | 1964-11-24 | Abbott Lab | 5-nitro-2-furylthioamide |
BE790569A (fr) * | 1971-10-27 | 1973-04-26 | Syntex Corp | Agents cardiovasculaires a base de thiazoles |
-
1973
- 1973-08-14 GB GB3950573A patent/GB1435139A/en not_active Expired
- 1973-08-15 NL NLAANVRAGE7311248,A patent/NL179733C/xx not_active IP Right Cessation
- 1973-08-16 CA CA178,970A patent/CA991640A/en not_active Expired
- 1973-08-16 FR FR7329860A patent/FR2196162B1/fr not_active Expired
- 1973-08-16 US US05/389,517 patent/US3932400A/en not_active Expired - Lifetime
- 1973-08-16 CH CH1182373A patent/CH581640A5/xx not_active IP Right Cessation
- 1973-08-16 DK DK452273A patent/DK149893C/da not_active IP Right Cessation
- 1973-08-16 SE SE7311181A patent/SE421615B/xx unknown
- 1973-08-17 DE DE2341753A patent/DE2341753C2/de not_active Expired
-
1974
- 1974-02-26 ZA ZA00741280A patent/ZA741280B/xx unknown
Also Published As
Publication number | Publication date |
---|---|
NL7311248A (xx) | 1974-02-19 |
ZA741280B (en) | 1975-03-26 |
DE2341753C2 (de) | 1982-12-09 |
NL179733C (nl) | 1986-11-03 |
US3932400A (en) | 1976-01-13 |
FR2196162B1 (xx) | 1977-01-28 |
FR2196162A1 (xx) | 1974-03-15 |
AU5928173A (en) | 1975-02-20 |
DK149893B (da) | 1986-10-20 |
CA991640A (en) | 1976-06-22 |
DE2341753A1 (de) | 1974-02-21 |
GB1435139A (en) | 1976-05-12 |
DK149893C (da) | 1987-04-21 |
CH581640A5 (xx) | 1976-11-15 |
NL179733B (nl) | 1986-06-02 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SE7614680L (sv) | Sett att framstella nya bensodiazepinderivat | |
SE417204B (sv) | Sett att framstella nya kinoxalin- och kinazolinderivat | |
SE421615B (sv) | Sett att framstella nya tiazolderivat | |
SE7711848L (sv) | Sett att framstella nya 5-metyl-7-hydroxi-isoflavonderivat | |
SE411349B (sv) | Sett att framstella nya penicilliner | |
SE410600B (sv) | Sett att framstella nya arylaminopyrimidinderivat | |
SE417982B (sv) | Sett att framstella cefalosporinforeningar | |
SE421690B (sv) | Sett att framstella bifunktionellt tverbundna insulinderivat | |
SE397830B (sv) | Sett att framstella nya bensodioxol-piperazinderivat | |
FI55029B (fi) | Foerfarande foer framstaellning av nya terapeutiskt aktiva isoindolinderivat | |
SE399255B (sv) | Sett att framstella kinazolinonderivat | |
SE386164B (sv) | Sett att framstella nya 2-alkylamino-dihydropyridiner | |
SE7603276L (sv) | Sett att framstella prostansyraderivat | |
SE417211B (sv) | Sett att framstella indenyl-3-acetoglucuronider | |
SE417981B (sv) | Sett att framstella cefalosporinforeningar | |
SE420087B (sv) | Sett att framstella bifunktionellt tverbundna insulinderivat | |
SE381257B (sv) | Sett att framstella rifamycinderivat | |
SE400078B (sv) | Sett att framstella kinazolinonderivat | |
SE405966B (sv) | Sett att framstella peptider | |
SE415564B (sv) | Sett att framstella nya cefalosporinderivat | |
SE413022B (sv) | Sett att framstella nya propylendiaminderivat | |
FI55198C (fi) | Foerfarande foer framstaellning av nya terapeutiskt aktiva isoindolinderivat | |
SE399712B (sv) | Sett att framstella pregnansyraderivat | |
SE400281B (sv) | Sett att framstella kinazolinonderivat | |
SE7610170L (sv) | Sett att framstella nya aminoimidazol-isokinolinderivat |